# Study of Drug Therapy for Pediatric Heart Failure

> **NCT06039540** · — · UNKNOWN · sponsor: **China National Center for Cardiovascular Diseases** · enrollment: 200 (estimated)

## Conditions studied

- Heart Failure Congenital

## Interventions

- **DRUG:** Captopril Tablets
- **DRUG:** Metoprolol Oral Tablet
- **DRUG:** Spironolactone Tablets
- **DRUG:** Torsemide Tablets
- **DRUG:** Potassium citrate powder

## Key facts

- **NCT ID:** NCT06039540
- **Lead sponsor:** China National Center for Cardiovascular Diseases
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-01
- **Primary completion:** 2024-06-22
- **Final completion:** 2024-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2023-09-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06039540

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06039540, "Study of Drug Therapy for Pediatric Heart Failure". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06039540. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*